These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 26596830

  • 1. The overexpression of miR-30a affects cell proliferation of chondrosarcoma via targeting Runx2.
    Jiang D, Zheng X, Shan W, Shan Y.
    Tumour Biol; 2016 May; 37(5):5933-40. PubMed ID: 26596830
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF, Dai H, Ou Q, Zuo GQ, Liu CA.
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
    Zhang C, Long F, Wan J, Hu Y, He H.
    Oncol Rep; 2016 Jun; 35(6):3275-84. PubMed ID: 27035764
    [Abstract] [Full Text] [Related]

  • 4. MiR-30a inhibits osteolysis by targeting RunX2 in giant cell tumor of bone.
    Huang Q, Jiang Z, Meng T, Yin H, Wang J, Wan W, Cheng M, Yan W, Liu T, Song D, Chen H, Wu Z, Xu W, Li Z, Zhou W, Xiao J.
    Biochem Biophys Res Commun; 2014 Oct 10; 453(1):160-5. PubMed ID: 25264196
    [Abstract] [Full Text] [Related]

  • 5. MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2.
    Zhang R, Yan S, Wang J, Deng F, Guo Y, Li Y, Fan M, Song Q, Liu H, Weng Y, Shi Q.
    Tumour Biol; 2016 Mar 10; 37(3):3479-88. PubMed ID: 26449831
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
    Taipaleenmäki H, Browne G, Akech J, Zustin J, van Wijnen AJ, Stein JL, Hesse E, Stein GS, Lian JB.
    Cancer Res; 2015 Apr 01; 75(7):1433-44. PubMed ID: 25634212
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
    Jia F, Zhang Z, Zhang X.
    J Cell Biochem; 2019 Apr 01; 120(4):6420-6430. PubMed ID: 30484892
    [Abstract] [Full Text] [Related]

  • 12. Epithelial microRNA-30a-3p targets RUNX2/HMGB1 axis to suppress airway eosinophilic inflammation in asthma.
    Wu W, Gao J, Chen D, Chen G, Feng Y, Chang C, Chen S, Yi L, Zhen G.
    Respir Res; 2022 Jan 29; 23(1):17. PubMed ID: 35093061
    [Abstract] [Full Text] [Related]

  • 13. miRNA-497 Negatively Regulates the Growth and Motility of Chondrosarcoma Cells by Targeting Cdc25A.
    Lu Y, Li F, Xu T, Sun J.
    Oncol Res; 2016 Jan 29; 23(4):155-63. PubMed ID: 27053344
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
    van der Deen M, Taipaleenmäki H, Zhang Y, Teplyuk NM, Gupta A, Cinghu S, Shogren K, Maran A, Yaszemski MJ, Ling L, Cool SM, Leong DT, Dierkes C, Zustin J, Salto-Tellez M, Ito Y, Bae SC, Zielenska M, Squire JA, Lian JB, Stein JL, Zambetti GP, Jones SN, Galindo M, Hesse E, Stein GS, van Wijnen AJ.
    J Biol Chem; 2013 Jul 19; 288(29):21307-21319. PubMed ID: 23720736
    [Abstract] [Full Text] [Related]

  • 15. miRNA-133a-5p Inhibits the Expression of Osteoblast Differentiation-Associated Markers by Targeting the 3' UTR of RUNX2.
    Zhang W, Wu Y, Shiozaki Y, Sugimoto Y, Takigawa T, Tanaka M, Matsukawa A, Ozaki T.
    DNA Cell Biol; 2018 Mar 19; 37(3):199-209. PubMed ID: 29359964
    [Abstract] [Full Text] [Related]

  • 16. MiR-122 inhibits cell proliferation and induces apoptosis by targeting runt-related transcription factors 2 in human glioma.
    Ding CQ, Deng WS, Yin XF, Ding XD.
    Eur Rev Med Pharmacol Sci; 2018 Aug 19; 22(15):4925-4933. PubMed ID: 30070328
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2.
    Fu J, Xu X, Kang L, Zhou L, Wang S, Lu J, Cheng L, Fan Z, Yuan B, Tian P, Zheng X, Yu C, Ye Q, Lv Z.
    Biochem Biophys Res Commun; 2014 Mar 07; 445(2):314-9. PubMed ID: 24508260
    [Abstract] [Full Text] [Related]

  • 19. MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2.
    Xie Y, Sun W, Deng Z, Zhu X, Hu C, Cai L.
    Sci Rep; 2017 Oct 17; 7(1):13388. PubMed ID: 29042587
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.